Drug Type Small molecule drug |
Synonyms |
Target |
Action antagonists |
Mechanism M5 receptor antagonists(Muscarinic acetylcholine receptor M5 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC15H16ClN5O3S |
InChIKeyURAUBDCJGRESTK-CQOLUAMGSA-N |
CAS Registry2746406-36-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nervous System Diseases | Discovery | United States | 06 Aug 2024 |